Back

Insilico’s AI drug rentosertib enters Phase 3 trials in China

Verifying
  • Insilico Medicine began Phase 3 testing of rentosertib in China.
  • 42 patients’ blood samples showed signs of reversed biological age in a study.
  • Insilico was founded in 2014 and has eight other drugs in Phase 1 trials.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.